Cargando…
Inhibition of p38 MAPK regulates epileptic severity by decreasing expression levels of A1R and ENT1
Epilepsy is a chronic nervous system disease. Excessive increase of the excitatory neurotransmitter glutamate in the body results in an imbalance of neurotransmitters and excessive excitation of neurons, leading to epileptic seizures. Long-term recurrent seizures lead to behavior and cognitive chang...
Autores principales: | Zhou, Xuejiao, Chen, Qian, Huang, Hao, Zhang, Jun, Wang, Jing, Chen, Ya, Peng, Yan, Zhang, Haiqing, Zeng, Junwei, Feng, Zhanhui, Xu, Zucai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647013/ https://www.ncbi.nlm.nih.gov/pubmed/33174009 http://dx.doi.org/10.3892/mmr.2020.11614 |
Ejemplares similares
-
Inhibition of p38 MAPK Signaling Regulates the Expression of EAAT2 in the Brains of Epileptic Rats
por: Yang, Zhang, et al.
Publicado: (2018) -
Glycyrrhizin regulates the HMGB1/P38MAPK signalling pathway in status epilepticus
por: Luo, Zhong, et al.
Publicado: (2023) -
Phosphoglycerate kinase (PGK) 1 succinylation modulates epileptic seizures and the blood-brain barrier
por: Luo, Yuemei, et al.
Publicado: (2023) -
Dynamic-related protein 1 inhibitor eases epileptic seizures and can regulate equilibrative nucleoside transporter 1 expression
por: Luo, Zhong, et al.
Publicado: (2020) -
The Progress in Diagnosis and Treatment of Exosomes and MicroRNAs on Epileptic Comorbidity Depression
por: Wei, Nian, et al.
Publicado: (2020)